Psoriatic arthritis in patients with psoriasis: Evaluation of clinical and epidemiological features in 133 patients followed at the University Hospital of Brasília;Artrite psoriásica em pacientes com psoríase: Avaliação de características clínicas e epidemiológicas em 133 pacientes atendidos no Hospital Universitário de Brasília

Anais Brasileiros de Dermatologia

Volumn 87, Issue 4, 2012, Pages 539-544

  Carneiro, Jamille Nascimento ^a   de Paula, Ana Patrícia ^b   Martins, Gladys Aires ^a  

^a UNIVERSITY OF BRASILIA   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Arthritis, psoriatic; Brazil; Psoriasis

Indexed keywords

ANTIINFECTIVE AGENT; BIOLOGICAL PRODUCT; C REACTIVE PROTEIN; DISEASE MODIFYING ANTIRHEUMATIC DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; BRAZIL; CLINICAL EVALUATION; CLINICAL FEATURE; CROSS-SECTIONAL STUDY; DACTYLITIS; DIABETES MELLITUS; ENTHESITIS; FEMALE; GUTTATE PSORIASIS; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NAIL PSORIASIS; PREVALENCE; PSORIASIS; PSORIATIC ARTHRITIS; PUSTULAR PSORIASIS; PUSTULOSIS PALMOPLANTARIS; SCALP;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ARTHRITIS, PSORIATIC; BRAZIL; CROSS-SECTIONAL STUDIES; FEMALE; HOSPITALS, UNIVERSITY; HUMANS; MALE; MIDDLE AGED; PREVALENCE; PSORIASIS; YOUNG ADULT;

EID: 84866393976     PISSN: 03650596     EISSN: 18064841     Source Type: Journal    
DOI: 10.1590/S0365-05962012000400003     Document Type: Article

References (23)

1. Sbd.org [Internet]. Sociedade Brasileira de Dermatologia. Consenso Brasileiro de Psoríase.2009. [acesso 5 Ago 2011]. Disponível em: http://www.sbd.org.br/flash/flash/Arquivos/Pdfs/ConsensoPsor%C3%ADase2009.pdf
2. Jamshidi F, Bouzari N, Seirafi H, Farnaghi F, Firooz A. The Prevalence of Psoriatic Arthritis in Psoriatic Patients in Tehran, Iran. Arch Iran Med. 2008;11:162-5.
3. Moghaddassi M, Shahram F, Chams-Davatchi C, Najafizadeh S, Davatchi F. Differentaspectofpsoriaticarthritis: analysisof 150 Iranianpatients. Arch Iran Med. 2009;12:279-83.
4. Gladman DD. Psoriatic arthritis from Wright's era until today. J Rheumatol. 2009;83:4-8.
5. Setty AR, Choi HK. Psoriatic arthritis epidemiology. Curr Rheumatol Rep. 2007;9:449-54.
6. Moll JMH, Wright V. Psoriatic arthritis. Semin Arthritis Rheum. 1973:3,55-78.
7. Gladman DD, Schentag CT, Tom BDM, Chandran V, Brockbank J, Rosen CF, et al. Development and initial validation of a screeningquestionnaire for psoriatic arthritis: The Toronto Psoriatic Arthritis Screen (ToPAS). Ann Rheum Dis. 2009;68:497-501.
8. Leung YY, Tam LS, Ho KW, Lau WM, Li TKY, Zhu TY, et al. Evaluation of the CASPAR criteria for psoriatic arthritis in the Chinese population. Rheumatology (Oxford). 2010;49:112-5.
9. Cantini F, Niccoli L, NanniniI C, Kaloudi O, Bertoni M, Cassara E. Psoriatic arthritis: a systematic review. Int J Rheum Dis. 2010;13:300-17.
10. Feldman SR, Krueger GG. Psoriasis assessment tools in clinical trials. Ann Rheum Dis. 2005;64 Suppl 2:ii65-8.
11. Sieper J, Rudwaleit M, Baraliakos X, Brandt J, Braun J, Burgos-Vargas R, et al. The Assessment of SpondyloArthritisinternational Society (ASAS) handbook: a guide to assess spondyloarthritis. Ann Rheum Dis. 2009;68 Suppl 2:ii1-44.
12. Taylor W, Gladman D, Helliwell P, Marchesoni A, Mease P, Mielants H, et al. Classification Criteria for Psoriatic Arthritis Development of New Criteria From a Large International Study. Arthritis Rheum. 2006;54:2665-73.
13. Altobelli E, Maccarone M, Petrocelli R, Marziliano C, Giannetti A, Peris K, et al. Analysis of health care and actual needs of patients with psoriasis: a survey on the Italian population. BMC Public Health. 2007;7:59.
14. Reich K, Kruger K, Mossner R, Augustin M. Epidemiology and clinical pattern of psoriatic arthritis in Germany: a prospective interdisciplinary epidemiological study of 1,511 patients with plaque-type psoriasis. Br J Dermatol. 2009;160:1040-7.
15. Ibrahim G, Waxman R, Helliwell PS. The prevalence of psoriatic arthritis in people with psoriasis. Arthritis Rheum. 2009;61:1373-8.
16. Aslanian FM, Lisboa FF, Iwamoto A, Carneiro SC. Clinical and epidemiological evaluation of psoriasis: clinical variants and articular manifestations. J Eur Acad Dermatol Venereol. 2005;19:141-2.
17. Trontzas P, Andrianakos A, Miyakis S, Pantelidou K, Vafiadou E, Garantziotou V, et al. Seronegative spondyloarthropathies in Greece: a population-based study of prevalence, clinical pattern, and management. The ESORDIG study. Clin Rheumatol. 2005;24:583-9.
18. Chandran V, Gottlieb A, Cook RJ, Duffin KC, Garg A, Helliwell P, et al. International Multi-centre Psoriasis and psoriatic Arthritis Reability Trial (GRAPPA-IMPART): Assessment of skin, joints, nails and dactylitis. Arthritis Rheum. 2009;61:1235-42.
19. Prey S, Paul C, Bronsard V, Puzenat E, Gourraud PA, Aractingi S, et al. Assessment of risk of psoriatic arthritis in patients with plaque psoriasis: a systematic review of the literature. J Eur Acad Dermatol Venereol. 2010;24 Suppl 2:31-35.
20. Wilson FC, Icen M, Crowson CS, Mcevoy MT, Gabriel SE, Kremers HM. Incidence and clinical predictors of psoriatic arthritis in patients ith psoriasis: a population-based study. Arthritis Rheum. 2009;61:233-9.
21. Gabay C, Kushner L. Acute phase proteins and other systemic responses to inflammation. N Engl J Med. 1999;340:448-54.
22. Bonfiglioli R, Conde RA, Sampaio-Barros PD, Louzada-Junior P, Donadi EA, Bertolo MB. Frequency of HLA-B27 alleles in Brazilian patients with psoriatic arthritis. Clin Rheumatol. 2008;27:709-12.
23. Gladman DD, Antoni C, Mease P, Clegg DO, Nash P. Psoriatic arthritis: epidemiology, clinical features, course, and outcome. Ann Rheum Dis. 2005;64 Suppl 2:ii14-7.